These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitative proteomics reveals a novel role of karyopherin alpha 2 in cell migration through the regulation of vimentin-pErk protein complex levels in lung cancer. Wang CI; Wang CL; Wu YC; Feng HP; Liu PJ; Chang YS; Yu JS; Yu CJ J Proteome Res; 2015 Apr; 14(4):1739-51. PubMed ID: 25728791 [TBL] [Abstract][Full Text] [Related]
4. mTOR regulates proteasomal degradation and Dp1/E2F1- mediated transcription of KPNA2 in lung cancer cells. Wang CI; Chen YY; Wang CL; Yu JS; Chang YS; Yu CJ Oncotarget; 2016 May; 7(18):25432-42. PubMed ID: 27009856 [TBL] [Abstract][Full Text] [Related]
5. Importin subunit alpha-2 is identified as a potential biomarker for non-small cell lung cancer by integration of the cancer cell secretome and tissue transcriptome. Wang CI; Wang CL; Wang CW; Chen CD; Wu CC; Liang Y; Tsai YH; Chang YS; Yu JS; Yu CJ Int J Cancer; 2011 May; 128(10):2364-72. PubMed ID: 20658535 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of KPNA2 in non-small-cell lung cancer is associated with Oct4 expression. Li XL; Jia LL; Shi MM; Li X; Li ZH; Li HF; Wang EH; Jia XS J Transl Med; 2013 Sep; 11():232. PubMed ID: 24070213 [TBL] [Abstract][Full Text] [Related]
7. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. Liao WC; Lin TJ; Liu YC; Wei YS; Chen GY; Feng HP; Chang YF; Chang HT; Wang CL; Chi HC; Wang CI; Lin KH; Ou Yang WT; Yu CJ Cancer Sci; 2022 Jan; 113(1):205-220. PubMed ID: 34773335 [TBL] [Abstract][Full Text] [Related]
8. Acetylation regulates the nucleocytoplasmic distribution and oncogenic function of karyopherin alpha 2 in lung adenocarcinoma. Feng HP; Liu YC; Wang CL; Liao WC; Yu JS; Yu CJ Biochem Biophys Res Commun; 2023 Jun; 659():96-104. PubMed ID: 37060831 [TBL] [Abstract][Full Text] [Related]
9. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc. Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078 [TBL] [Abstract][Full Text] [Related]
10. KPNA2 promotes cell proliferation and tumorigenicity in epithelial ovarian carcinoma through upregulation of c-Myc and downregulation of FOXO3a. Huang L; Wang HY; Li JD; Wang JH; Zhou Y; Luo RZ; Yun JP; Zhang Y; Jia WH; Zheng M Cell Death Dis; 2013 Aug; 4(8):e745. PubMed ID: 23907459 [TBL] [Abstract][Full Text] [Related]
11. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation. Ma S; Zhao X Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899 [TBL] [Abstract][Full Text] [Related]
12. KPNA2 interacts with P65 to modulate catabolic events in osteoarthritis. Tao R; Xu X; Sun C; Wang Y; Wang S; Liu Z; Zhai L; Cheng H; Xiao M; Zhang D Exp Mol Pathol; 2015 Oct; 99(2):245-52. PubMed ID: 26209501 [TBL] [Abstract][Full Text] [Related]
13. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Xiang S; Wang Z; Ye Y; Zhang F; Li H; Yang Y; Miao H; Liang H; Zhang Y; Jiang L; Hu Y; Zheng L; Liu X; Liu Y Oncogene; 2019 Feb; 38(8):1269-1281. PubMed ID: 30254209 [TBL] [Abstract][Full Text] [Related]
14. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer. Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145 [TBL] [Abstract][Full Text] [Related]
15. Karyopherin alpha2 is essential for rRNA transcription and protein synthesis in proliferative keratinocytes. Umegaki-Arao N; Tamai K; Nimura K; Serada S; Naka T; Nakano H; Katayama I PLoS One; 2013; 8(10):e76416. PubMed ID: 24098495 [TBL] [Abstract][Full Text] [Related]
16. Silencing KPNA2 inhibits IL-6-induced breast cancer exacerbation by blocking NF-κB signaling and c-Myc nuclear translocation in vitro. Duan M; Hu F; Li D; Wu S; Peng N Life Sci; 2020 Jul; 253():117736. PubMed ID: 32360571 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1. Umegaki N; Tamai K; Nakano H; Moritsugu R; Yamazaki T; Hanada K; Katayama I; Kaneda Y J Invest Dermatol; 2007 Jun; 127(6):1456-64. PubMed ID: 17255955 [TBL] [Abstract][Full Text] [Related]
18. Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach. Pan ST; Zhou ZW; He ZX; Zhang X; Yang T; Yang YX; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():937-68. PubMed ID: 25733813 [TBL] [Abstract][Full Text] [Related]
19. Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy. He J; Yang L; Chang P; Yang S; Lin S; Tang Q; Wang X; Zhang YJ Autophagy; 2020 Dec; 16(12):2238-2251. PubMed ID: 32924767 [TBL] [Abstract][Full Text] [Related]
20. Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinoma. Yang Y; Guo J; Hao Y; Wang F; Li F; Shuang S; Wang J Oncotarget; 2017 May; 8(22):36289-36304. PubMed ID: 28422734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]